Entity Common Stock, Shares Outstanding of Celldex Therapeutics, Inc. from 01 Aug 2011 to 29 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Celldex Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 29 Oct 2025.
  • Celldex Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 29 Oct 2025 was 66,449,471, a 0.16% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Celldex Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 66,449,471 +105,235 +0.16% 29 Oct 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 66,406,544 +118,948 +0.18% 28 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 66,394,241 +483,693 +0.73% 30 Apr 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 66,383,811 +10,483,132 +19% 14 Feb 2025 10-K 27 Feb 2025 2024 FY
Q3 2024 66,344,236 +19,080,039 +40% 29 Oct 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 66,287,596 +19,026,792 +40% 31 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 65,910,548 +18,658,079 +39% 30 Apr 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 55,900,679 +8,693,490 +18% 14 Feb 2024 10-K 26 Feb 2024 2023 FY
Q3 2023 47,264,197 +164,366 +0.35% 27 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 47,260,804 +488,453 +1% 31 Jul 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 47,252,469 +498,121 +1.1% 28 Apr 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 47,207,189 13 Feb 2023 10-K 28 Feb 2023 2022 FY
Q3 2022 47,099,831 +435,959 +0.93% 31 Oct 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 46,772,351 +290,508 +0.62% 29 Jul 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 46,754,348 +7,139,710 +18% 29 Apr 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 46,663,872 +7,096,807 +18% 31 Oct 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 46,481,843 +7,355,395 +19% 31 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 39,614,638 +22,039,959 +125% 22 Mar 2021 10-K 29 Mar 2021 2020 FY
Q3 2020 39,567,065 +23,436,960 +145% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 39,126,448 +24,107,844 +161% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 17,574,679 +3,805,801 +28% 13 Mar 2020 10-K 26 Mar 2020 2019 FY
Q3 2019 16,130,105 -156,335,462 -91% 31 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 15,018,604 -147,423,728 -91% 31 Jul 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 13,768,878 -127,304,790 -90% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 172,465,567 +36,480,238 +27% 31 Oct 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 162,442,332 +34,100,547 +27% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 141,073,668 +17,860,230 +14% 28 Feb 2018 10-K 07 Mar 2018 2017 FY
Q3 2017 135,985,329 +34,736,508 +34% 31 Oct 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 128,341,785 +27,796,266 +28% 31 Jul 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 123,213,438 +24,494,922 +25% 06 Mar 2017 10-K 14 Mar 2017 2016 FY
Q3 2016 101,248,821 +2,603,129 +2.6% 31 Oct 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 100,545,519 +1,950,112 +2% 31 Jul 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 98,718,516 +237,697 +0.24% 26 Apr 2016 10-Q 05 May 2016 2016 Q1
Q3 2015 98,645,692 +9,056,587 +10% 27 Oct 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 98,595,407 +9,191,646 +10% 28 Jul 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 98,480,819 +9,122,976 +10% 22 Apr 2015 10-Q 29 Apr 2015 2015 Q1
Q3 2014 89,589,105 +8,480,871 +10% 31 Oct 2014 10-Q 05 Nov 2014 2014 Q3
Q2 2014 89,403,761 +8,415,890 +10% 28 Jul 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 89,357,843 +8,487,523 +10% 22 Apr 2014 10-Q 01 May 2014 2014 Q1
Q3 2013 81,108,234 +19,133,114 +31% 29 Oct 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 80,987,871 +21,695,800 +37% 29 Jul 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 80,870,320 +22,134,684 +38% 24 Apr 2013 10-Q 03 May 2013 2013 Q1
Q3 2012 61,975,120 +17,827,906 +40% 30 Oct 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 59,292,071 +15,144,857 +34% 31 Jul 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 58,735,636 26 Apr 2012 10-Q 04 May 2012 2012 Q1
Q3 2011 44,147,214 31 Oct 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 44,147,214 01 Aug 2011 10-Q 04 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.